DEF: Sonder Holdings Seeks Stockholder Approval for Share Issuance and Authorized Share Increase
Proxy Statement
Sonder Holdings is holding a special meeting of stockholders to approve the issuance of shares related to preferred stock conversion and warrants, as well as an amendment to increase the company's authorized shares.
Summary
- Sonder Holdings Inc. is seeking stockholder approval for three proposals at a special meeting on June 6, 2025.
- Proposal 1 involves approving the issuance of common stock upon conversion of preferred shares and exercise of NPA Warrants to comply with Nasdaq Listing Rules.
- Proposal 2 aims to amend the company's certificate of incorporation to increase authorized shares from 409,309,144 to 462,921,255.
- This includes increasing general common stock to 212,921,255 shares and maintaining 250,000,000 shares of preferred stock.
- Proposal 3 concerns the potential adjournment of the special meeting to solicit additional proxies if necessary.
- The record date for the special meeting is April 9, 2025.
- The company intends to use proceeds from a recent private placement for working capital and general corporate purposes.
- As of the record date, there were 12,885,481 shares of common stock and 26,669,003 shares of Series A Preferred Stock outstanding and entitled to vote.
- The Board recommends voting FOR all three proposals.
Sentiment
Score: 6
Explanation: The document is primarily factual and procedural, outlining proposals for stockholder approval. While the actions aim to secure funding, there are potential dilutive effects and risks associated with the proposals, resulting in a neutral sentiment.
Positives
- The proposed actions aim to secure necessary funding for working capital and general corporate purposes.
- Existing stockholders holding a significant portion of voting capital stock have agreed to vote in favor of the Nasdaq Proposal.
- The virtual meeting format enhances stockholder access and engagement.
- The company has secured agreements to ensure the Preferred Shares are convertible into up to 19.99% of the outstanding shares of common stock on April 11, 2025.
Negatives
- Approval of the Nasdaq Proposal will result in dilution of existing stockholders' ownership.
- The potential for significant stockholders to exercise control over the company could delay or prevent a change of control.
- The sale of Conversion Shares into the public market could adversely affect the market price of the common stock.
- Abstentions and broker non-votes will have the same effect as votes against the Share Increase Amendment Proposal.
Risks
- Failure to obtain stockholder approval for the proposals could hinder the company's ability to raise capital and execute its business plan.
- The market price of the common stock could be negatively impacted by the issuance of new shares.
- Significant stockholders may exercise a significant level of control over all matters requiring stockholder approval.
- The company may face challenges in maintaining compliance with Nasdaq Listing Rules.
Future Outlook
The company intends to file a registration statement with the SEC covering resales of the Conversion Shares and use commercially reasonable efforts to have it declared effective.
Industry Context
The document does not provide specific details on how this announcement relates to broader industry trends or competitors.
Stakeholder Impact
- Shareholders will be impacted by the potential dilution of their ownership interest.
- The company's ability to raise capital and execute its business plan will be affected by the outcome of the stockholder vote.
Next Steps
- Stockholders will vote on the proposals at the Special Meeting on June 6, 2025.
- The company will file a registration statement for the resale of Conversion Shares.
- The Board will determine the timing of filing the Share Increase Amendment if approved.
Key Dates
| Date | Description |
|---|---|
| December 10, 2021 | Date of the Note and Warrant Purchase Agreement (NPA). |
| August 13, 2024 | Date of Certificate of Designation filed with the Delaware Secretary of State. |
| December 23, 2024 | Date of Certificate of Amendment of Amended and Restated Certificate of Incorporation filed with the Secretary of State. |
| December 31, 2024 | End of fiscal year for which the company will file its Annual Report on Form 10-K. |
| April 9, 2025 | Record date for the Special Meeting. |
| April 10, 2025 | Date the Board approved the amendment to the Certificate of Incorporation. |
| April 11, 2025 | Date the company entered into Securities Purchase Agreements and issued Preferred Shares and NPA Warrants. |
| May 15, 2025 | Date the proxy statement is first being sent to stockholders. |
| June 5, 2025 | Deadline to vote by proxy through the Internet or telephone. |
| June 6, 2025 | Date of the Special Meeting of Stockholders. |
| July 1, 2025 | Date before which the Company may only issue up to 1.5 million shares of common stock, except in connection with obtaining the approval of the Requisite Holders. |
| July 11, 2025 | Deadline for stockholders to submit proposals for inclusion in the proxy statement for the 2025 Annual Meeting. |
| August 25, 2025 | Earliest date for stockholders to submit director nominations or proposals for consideration at the 2025 Annual Meeting. |
| September 24, 2025 | Latest date for stockholders to submit director nominations or proposals for consideration at the 2025 Annual Meeting. |
| April 11, 2030 | Expiration date of the NPA Warrants. |
Keywords
stockholder approval, preferred shares, NPA warrants, authorized shares, common stock, Nasdaq, dilution, conversion, special meeting, proxy statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.